International Marijuana Business News – Middle East
Israeli cannabis producer InterCure’s proposed acquisition of rival medical marijuana company Cann Pharmaceutical, also known as Better, was terminated after the companies failed to bridge differences.
Publicly traded international medical cannabis company IM Cannabis Corp. is launching two non-brokered private placements to raise as much as $5.5 million.
Israeli police told the operators of the cargo terminal at Ben Gurion Airport, the country’s main international airfield, to stop shipments of medical marijuana, The Israeli Cannabis Magazine reported.
Herzliya, Israel-based cannabis producer InterCure is buying rival medical marijuana company Cann Pharmaceutical, also known as Better, for $35 million (44.4 million Canadian dollars) in stock.
IMC Holdings, the Israeli subsidiary of IM Cannabis Corp., hired Rinat Efrima as its new chief executive officer, the company announced.
Edmonton, Alberta-based Aurora Cannabis sent its largest ever shipment of medical marijuana to the fast-expanding Israeli market, the company announced Tuesday.
